Khalid Shoumariyeh

12PUBLICATIONS
150CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursInnate immunityMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 20, 2026
The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1.

Khalid Shoumariyeh, Stefan Haug, Juliana Schwaab

|Oct 03, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Melissa Zwick, Bastian Zinkel, Corinna Spohr

|Jul 12, 2025
Modeling the t(2;5) Translocation of Anaplastic Large Cell Lymphoma Using CRISPR-Mediated Chromosomal Engineering.

Robin Khan, Laurent Phely, Sophia Ehrenfeld

|Nov 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.

Khalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei

|Jun 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Dominik Schmidt, Cornelia Endres, Rouven Hoefflin

|Aug 04, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Petya Apostolova, Stefanie Kreutmair, Cristina Toffalori

Pageof 2

Frequent Collaborators

6 joint publications

Robert Zeiser

5 joint publications

Tilman Brummer

4 joint publications

Melanie Boerries

4 joint publications

Justus Duyster